<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Helmut Schütz" />

<meta name="date" content="2019-06-07" />

<title>replicateBE</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' || rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">replicateBE</h1>
<h3 class="subtitle">Comparative BA-calculation for the EMA’s Average Bioequivalence with Expanding Limits (ABEL)</h3>
<h4 class="author">Helmut Schütz</h4>
<h4 class="date">2019-06-07</h4>



<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="kw">suppressMessages</span>(<span class="kw">library</span>(replicateBE))</a></code></pre></div>
<ul>
<li><a href="#disclaimer">Disclaimer</a></li>
<li><a href="#intro">Introduction</a></li>
<li><a href="#methods">Methods</a>
<ul>
<li><a href="#methodA">Method A</a></li>
<li><a href="#methodB">Method B</a></li>
<li><a href="#ABE">ABE</a></li>
</ul></li>
<li><a href="#designs">Tested designs</a>
<ul>
<li><a href="#per4_full">Four period (full) replicates</a></li>
<li><a href="#per3_full">Three period (full) replicates</a></li>
<li><a href="#per2_full">Two period (full) replicate</a></li>
<li><a href="#per3_part">Three period (partial) replicates</a></li>
</ul></li>
<li><a href="#data_struct">Data structure</a>
<ul>
<li><a href="#incomplete">Incomplete data</a>
<ul>
<li><a href="#setCW">Estimation of <em>CV<sub>w</sub></em></a></li>
<li><a href="#setBE">Assessment of BE</a></li>
<li><a href="#setexpl">Example of different data sets</a></li>
</ul></li>
</ul></li>
<li><a href="#notes">Notes on the methods</a>
<ul>
<li><a href="#cv">Estimation of intra-subject variability</a></li>
<li><a href="#model_struc">Model structure</a></li>
<li><a href="#BElim">ABE limits, rounding issues</a></li>
<li><a href="#df_comp">Degrees of freedom, comparison of methods</a></li>
<li><a href="#ola">Outlier analysis</a></li>
</ul></li>
<li><a href="#app_out">Applicability, outlook</a></li>
<li><a href="#cross">Cross-validation</a></li>
<li><a href="#contr">Contributors</a></li>
<li><a href="#session">Session Information</a></li>
</ul>
<hr />
<div id="disclaimer" class="section level3">
<h3>Disclaimer</h3>
<p><strong>Program offered for Use without any Guarantees and Absolutely No Warranty. No Liability is accepted for any Loss and Risk to Public Health Resulting from Use of this R-Code.</strong></p>
</div>
<div id="intro" class="section level3">
<h3>Introduction</h3>
<p>The library provides data sets (internal <code>.rda</code> and in CSV-format in <code>/extdata/</code>) given by Schütz <em>et al</em>.<a href="#fn1" class="footnote-ref" id="fnref1"><sup>1</sup></a> which support users in a black-box performance qualification (PQ) of their software installations.</p>
<p>The methods given in the EMA’s <a href="https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-positions-specific-questions-addressed-pharmacokinetics-working-party_en.pdf" title="EMA, January 2011 and later revisions">Q&amp;A document</a> for reference-scaling according to the EMA’s <a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf" title="EMA, January 2010">Guideline on the Investigation of Bioequivalence</a> are implemented. Potential influence of outliers on the variability of the reference can be assessed by box plots of studentized and standardized residuals as suggested at a joint <a href="https://www.medicinesforeurope.com/wp-content/uploads/2016/03/EGA_BEQ_QA_WEB_QA_1_32.pdf" title="London, June 2010">EGA/EMA workshop</a>.</p>
</div>
<div id="methods" class="section level3">
<h3>Methods</h3>
<div id="function-method.a" class="section level4">
<h4>function <code id="methodA">method.A()</code></h4>
<p>A linear model of log-transformed PK responses and effects<br />
    <em>sequence</em>, <em>subject(sequence)</em>, <em>period</em>, <em>treatment</em><br />
where all effects are fixed (<em>i.e.</em>, ANOVA). Estimated via function <code>lm()</code> of library <code>stats</code>.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1">modA &lt;-<span class="st"> </span><span class="kw">lm</span>(<span class="kw">log</span>(PK) <span class="op">~</span><span class="st"> </span>sequence <span class="op">+</span><span class="st"> </span>subject<span class="op">%in%</span>sequence <span class="op">+</span><span class="st"> </span>period <span class="op">+</span><span class="st"> </span>treatment,</a>
<a class="sourceLine" id="cb2-2" title="2">                     <span class="dt">data =</span> data)</a></code></pre></div>
</div>
<div id="function-method.b" class="section level4">
<h4>function <code id="methodB">method.B()</code></h4>
<p>A linear model of log-transformed PK responses and effects<br />
    <em>sequence</em>, <em>subject(sequence)</em>, <em>period</em>, <em>treatment</em><br />
where <em>subject(sequence)</em> is a random effect and all others are fixed.<br />
Two options are provided</p>
<ol style="list-style-type: decimal">
<li>Estimated via function <code>lmer()</code> of library <code>lmerTest</code>. Uses Satterthwaite’s degrees of freedom.<br />
<code>method.B(..., option = 1)</code></li>
</ol>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb3-1" title="1">modB &lt;-<span class="st"> </span><span class="kw">lmer</span>(<span class="kw">log</span>(PK) <span class="op">~</span><span class="st"> </span>sequence <span class="op">+</span><span class="st"> </span>period <span class="op">+</span><span class="st"> </span>treatment <span class="op">+</span><span class="st"> </span>(<span class="dv">1</span><span class="op">|</span>subject),</a>
<a class="sourceLine" id="cb3-2" title="2">                       <span class="dt">data =</span> data)</a></code></pre></div>
<ol start="2" style="list-style-type: decimal">
<li>Estimated via function <code>lme()</code> of library <code>nlme</code>. Uses degrees of freedom equivalent to SAS’ <code>DDFM=CONTAIN</code> and Phoenix/WinNonlin’s <code>DF Residual</code>. Implicitly preferred according to the Q&amp;A document.<br />
<code>method.B(..., option = 2)</code>, the default.<br />
</li>
</ol>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1">modB &lt;-<span class="st"> </span><span class="kw">lme</span>(<span class="kw">log</span>(PK) <span class="op">~</span><span class="st"> </span>sequence <span class="op">+</span><span class="st">  </span>period <span class="op">+</span><span class="st"> </span>treatment, <span class="dt">random =</span> <span class="op">~</span><span class="dv">1</span><span class="op">|</span>subject,</a>
<a class="sourceLine" id="cb4-2" title="2">                     <span class="dt">data =</span> data)</a></code></pre></div>
</div>
<div id="function-abe" class="section level4">
<h4>function <code id="ABE">ABE()</code></h4>
<p>Conventional Average Bioequivalence, where the model is identical to <a href="#methodA">Method A</a>. Tighter limits for narrow therapeutic index drugs (EMA 90.00 – 111.11%) or wider limits (75.00 – 133.33% for C<sub>max</sub> according to the guideline of the GCC<a href="#fn2" class="footnote-ref" id="fnref2"><sup>2</sup></a>) can be specified.</p>
</div>
</div>
<div id="designs" class="section level3">
<h3>Tested designs</h3>
<div id="per4_full" class="section level4">
<h4>Four period (full) replicates</h4>
<p>Both the test and the reference treatments are administered at least once.</p>
<p><code>TRTR | RTRT</code><br />
<code>TRRT | RTTR</code><br />
<code>TTRR | RRTT</code><br />
<code>TRTR | RTRT | TRRT | RTTR</code> <a href="#fn3" class="footnote-ref" id="fnref3"><sup>3</sup></a><br />
<code>TRRT | RTTR | TTRR | RRTT</code> <a href="#fn4" class="footnote-ref" id="fnref4"><sup>4</sup></a></p>
</div>
<div id="per3_full" class="section level4">
<h4>Three period (full) replicates</h4>
<p>The test treatment is administered at least once to ½ of the subjects and the reference treatment at least once to the respective other ½ of the subjects.</p>
<p><code>TRT | RTR</code><br />
<code>TRR | RTT</code></p>
</div>
<div id="per2_full" class="section level4">
<h4>Two period (full) replicate</h4>
<p>The test and reference treatments are administered once to ½ of the subjects (for the estimation of the CI). <em>I.e.</em>, the first group of subjects follow a conventional 2×2×2 trial. In the second group the test and reference treatments are administered at least once to ¼ of the subjects, repectively (for the estimation of <em>CV<sub>wT</sub></em> and <em>CV<sub>wR</sub></em>).</p>
<p><code>TR | RT | TT | RR</code> <a href="#fn5" class="footnote-ref" id="fnref5"><sup>5</sup></a></p>
</div>
<div id="per3_part" class="section level4">
<h4>Three period (partial) replicates</h4>
<p>The test treatment is administered once and the reference treatment at least once.</p>
<p><code>TRR | RTR | RRT</code><br />
<code>TRR | RTR</code> <a href="#fn6" class="footnote-ref" id="fnref6"><sup>6</sup></a></p>
</div>
</div>
<div id="data_struct" class="section level3">
<h3>Data structure</h3>
<p>Columns must have the headers <code>subject</code>, <code>period</code>, <code>sequence</code>, <code>treatment</code>, <code>PK</code>, and/or <code>logPK</code>.<a href="#fn7" class="footnote-ref" id="fnref7"><sup>7</sup></a> Any order of columns is acceptable. Uppercase and mixed case headers will be internally converted to lowercase headers.</p>
<table>
<colgroup>
<col width="9%"></col>
<col width="90%"></col>
</colgroup>
<thead>
<tr class="header">
<th>variable</th>
<th>format</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><code>subject</code></td>
<td>Integer numbers or any combination of alphanumerics (A-Z, a-z, -, _, #, 0-9)</td>
</tr>
<tr class="even">
<td><code>period</code></td>
<td>Integer numbers</td>
</tr>
<tr class="odd">
<td><code>sequence</code></td>
<td>Numbers or any other literal sequences not listed in the <a href="#designs">tested designs</a> are not accepted (<em>e.g.</em>, <code>ABAB</code>).</td>
</tr>
<tr class="even">
<td><code>treatment</code></td>
<td>The Test treatment must be coded <code>T</code> and the Reference <code>R</code> (both uppercase).</td>
</tr>
</tbody>
</table>
<p>Relevant data are used for the estimation of <em>CV<sub>wR</sub></em> (and <em>CV<sub>wT</sub></em> in full replicate designs) and BE, <em>i.e.</em>, the data sets might be different. It is good practice to state that in the SAP.</p>
<div id="incomplete" class="section level4">
<h4>Incomplete data</h4>
<div id="setCW" class="section level5">
<h5>Estimation of <em>CV<sub>w</sub></em></h5>
<p>If a subject drops out from the study in a higher period, data of repeated administrations will still be used for the estimation of <em>CV<sub>w</sub></em>, although data of the other treatment might be missing. Examples for the estimation of <em>CV<sub>wR</sub></em> (missings denoted by <code>.</code>):<br />
<code>RTRT</code> → <code>RTR.</code><br />
<code>TRRT</code> → <code>TRR.</code><br />
<code>RRTT</code> → <code>RRT.</code> or <code>RR..</code><br />
<code>RRT</code> → <code>RR..</code><br />
</p>
</div>
<div id="setBE" class="section level5">
<h5>Assessment of BE</h5>
<p>If a subject drops out from the study in a higher period, data with at least one administration of the Test and Reference will be used in the assessment of BE. Examples (missings denoted by <code>.</code>):<br />
</p>
<p><code>TRTR</code> → <code>TRT.</code> or → <code>TR..</code><br />
<code>RTRT</code> → <code>RTR.</code> or → <code>RT..</code><br />
<code>TRRT</code> → <code>TRR.</code> or → <code>TR..</code><br />
<code>RTTR</code> → <code>RTT.</code> or → <code>RT..</code><br />
<code>TTRR</code> → <code>TTR.</code><br />
<code>TRT</code> → <code>TR.</code><br />
<code>RTR</code> → <code>RT.</code><br />
<code>TRR</code> → <code>TR.</code><br />
<code>RTR</code> → <code>RT.</code><br />
<code>RTT</code> → <code>RT.</code><br />
</p>
</div>
<div id="setexpl" class="section level5">
<h5>Example of different data sets</h5>
<p>16 subjects included. In sequence <code>RTRT</code> one dropout in the 2<sup>nd</sup> period and one in the 4<sup>th</sup> period. In sequence <code>TRTR</code> one dropout in the 3<sup>rd</sup> period and one in the 4<sup>th</sup>.<br />
</p>
<p><code>1  RTR.    5  RTRT    9  TRTR   13  RTRT</code><br />
<code>2  RTRT    6  TR..   10  TRTR   14  TRT.</code><br />
<code>3  RTRT    7  RTRT   11  RTRT   15  TRTR</code><br />
<code>4  TRTR    8  R...   12  TRTR   16  TRTR</code></p>
<p>We obtain two data sets:</p>
<ol style="list-style-type: decimal">
<li>13 subjects for the estimation of <em>CV<sub>wR</sub></em> (insufficient data of subjects 6, 8, and 14).</li>
<li>15 subjects who received at least one treatment <code>T</code> and <code>R</code> for the assessment of BE (all except subject 8).</li>
</ol>
</div>
</div>
</div>
<div id="notes" class="section level3">
<h3>Notes on the methods</h3>
<div id="cv" class="section level4">
<h4>Estimation of intra-subject variability</h4>
<p>The EMA proposed a linear model of log-transformed PK responses of the reference<br />
    <em>sequence</em>, <em>subject(sequence)</em>, <em>period</em><br />
where all effects are fixed. Estimated via function <code>lm()</code> of library <code>stats</code>:</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1">modCV &lt;-<span class="st"> </span><span class="kw">lm</span>(<span class="kw">log</span>(PK) <span class="op">~</span><span class="st"> </span>sequence <span class="op">+</span><span class="st"> </span>subject<span class="op">%in%</span>sequence <span class="op">+</span><span class="st"> </span>period,</a>
<a class="sourceLine" id="cb5-2" title="2">                      <span class="dt">data =</span> data[data<span class="op">$</span><span class="dt">treatment =</span> <span class="st">&quot;R&quot;</span>, ])</a></code></pre></div>
<p>For informational purposes in full replicate designs (required by the WHO for reference-scaling of AUC) the same model is additionaly run with <code>data = data[data$treatment = &quot;T&quot;, ]</code>.</p>
<p>Special conditions for the sample size in three period full replicate designs:</p>
<blockquote>
<p><em>The question raised asks if it is possible to use a design where subjects are randomised to receive treatments in the order of TRT or RTR.</em></p>
<p><em>[…] if a 3-period replicate design, where treatments are given in the order TRT or RTR, is to be used to justify widening of a confidence interval for C<sub>max</sub> then it is considered that at least 12 patients would need to provide data from the RTR arm. This implies a study with at least 24 patients in total would be required if equal number of subjects are allocated to the 2 treatment sequences.</em></p>
<p>— <a href="https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-positions-specific-questions-addressed-pharmacokinetics-working-party_en.pdf">Q&amp;A document</a> (June 2015 and later revisions)</p>
</blockquote>
<p>If less than twelve subjects remain in sequence <code>RTR</code> of a <code>TRT | RTR</code> design (and in analogy in sequence <code>TRR</code> of a <code>TRR | RTT</code> design), the user is notified about the uncertain estimate of <em>CV<sub>wR</sub></em>. However, in a sufficiently powered study such a case is <a href="https://forum.bebac.at/mix_entry.php?id=15139" title="BEBA Forum, July 2015">extremely unlikely</a>.</p>
</div>
<div id="model_struc" class="section level4">
<h4>Model structure</h4>
<p>The EMA’s models assumes equal [<em>sic</em>] intra-subject variances of Test and Reference (like in 2×2×2 trials) – even if proven false in one of the full replicate designs (were <em>both</em> <em>CV<sub>wT</sub></em> and <em>CV<sub>wR</sub></em> can be estimated). Hence, amongst bio­statis­ticians it is called the ‘crippled model’ because the replicative nature of the study is ignored.</p>
<p>The nested structure <em>subject(sequence)</em> of the <a href="#methods">methods</a> leads to an over-specificed model.<a href="#fn8" class="footnote-ref" id="fnref8"><sup>8</sup></a> The simple model<br />
    <em>sequence</em>, <em>subject</em>, <em>period</em>, <em>treatment</em><br />
gives identical estimates of the residual variance and the treatment effect and hence, its confidence interval.</p>
<p>The same holds true for the <a href="#cv">EMA’s model</a> to estimate <em>CV<sub>wR</sub></em>. The simple model<br />
    <em>subject</em>, <em>period</em><br />
gives an identical estimate of the residual variance.</p>
<p>Reference-scaling is acceptable for C<sub>max</sub> (immediate release products<a href="#fn9" class="footnote-ref" id="fnref9"><sup>9</sup></a>) and C<sub>max</sub>, C<sub>max,ss</sub>, C<sub>τ,ss</sub>, <sub>partial</sub>AUC (modified release products<a href="#fn10" class="footnote-ref" id="fnref10"><sup>10</sup></a>) if high variability of the reference product (<em>CV<sub>wR</sub></em> &gt;30%) was demonstrated.</p>
<p>The intention to widen the limits has to be stated in the protocol and – contrary to the FDA’s RSABE – a clinical justification provided.</p>
<blockquote>
<p><em>Those HVDP for which a wider difference in C<sub>max</sub> is considered clinically irrelevant based on a sound clinical justification can be assessed with a widened acceptance range. The request for widened inter­val must be prospectively specified in the protocol.</em></p>
<p>— <a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf">BE Guideline</a> (January 2010)</p>
</blockquote>
</div>
<div id="BElim" class="section level4">
<h4>ABE limits, rounding issues</h4>
<p>The limits can be expanded based on <em>CV<sub>wR</sub></em>.</p>
<ul>
<li><em>CV<sub>wR</sub></em> ≤ 30%<br />
Lower cap, <em>i.e.</em>, no scaling, conventional limits:<br />
<small><span class="math inline">\(\left[ {L,U} \right] = {80.00 - 125.00\%}\)</span></small></li>
<li>30% &lt; <em>CV<sub>wR</sub></em> ≤ 50%<br />
Expanded limits based on <span class="math inline">\(s_{wR}\)</span>:<br />
<small><span class="math inline">\(\left[ {L,U} \right] = 100{e^{ \mp 0.760 \cdot {s_{wR}}}}\)</span></small></li>
<li><em>CV<sub>wR</sub></em> &gt; 50%<br />
Upper cap, <em>i.e.</em>, applying <small><span class="math inline">\(s^*_{wR}=\sqrt{log(0.50^2+1)}\)</span></small> in the expansion formula or<br />
<small><span class="math inline">\(\left[ {L,U} \right] = {69.84 - 143.19\%}\)</span></small>.</li>
</ul>
<p>In order to avoid small discontinuities at <em>CV<sub>wR</sub></em> ≈ 50% (due to double rounding), the expanded limits are calculated in full numeric precision and only the CI is rounded according to the GL.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1"><span class="co"># Calculate limits with library PowerTOST</span></a>
<a class="sourceLine" id="cb6-2" title="2">CV &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">29</span>, <span class="kw">seq</span>(<span class="dv">30</span>, <span class="dv">50</span>, <span class="dt">by =</span> <span class="dv">5</span>), <span class="dv">51</span>)</a>
<a class="sourceLine" id="cb6-3" title="3">df &lt;-<span class="st"> </span><span class="kw">data.frame</span>(<span class="dt">CV =</span> CV, <span class="dt">L =</span> <span class="ot">NA</span>, <span class="dt">U =</span> <span class="ot">NA</span>, <span class="dt">cap =</span> <span class="st">&quot;&quot;</span>,</a>
<a class="sourceLine" id="cb6-4" title="4">                 <span class="dt">stringsAsFactors =</span> <span class="ot">FALSE</span>)</a>
<a class="sourceLine" id="cb6-5" title="5"><span class="cf">for</span> (i <span class="cf">in</span> <span class="kw">seq_along</span>(CV)) {</a>
<a class="sourceLine" id="cb6-6" title="6">  df[i, <span class="dv">2</span><span class="op">:</span><span class="dv">3</span>] &lt;-<span class="st"> </span><span class="kw">sprintf</span>(<span class="st">&quot;%.8f&quot;</span>, PowerTOST<span class="op">:::</span><span class="kw">scABEL</span>(CV[i]<span class="op">/</span><span class="dv">100</span>)<span class="op">*</span><span class="dv">100</span>)</a>
<a class="sourceLine" id="cb6-7" title="7">}</a>
<a class="sourceLine" id="cb6-8" title="8">df<span class="op">$</span>cap[df<span class="op">$</span>CV <span class="op">&lt;=</span><span class="st"> </span><span class="dv">30</span>] &lt;-<span class="st"> &quot;lower&quot;</span></a>
<a class="sourceLine" id="cb6-9" title="9">df<span class="op">$</span>cap[df<span class="op">$</span>CV <span class="op">&gt;=</span><span class="st"> </span><span class="dv">50</span>] &lt;-<span class="st"> &quot;upper&quot;</span></a>
<a class="sourceLine" id="cb6-10" title="10"><span class="kw">names</span>(df)[<span class="dv">1</span><span class="op">:</span><span class="dv">3</span>] &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="st">&quot;CV(%)&quot;</span>, <span class="st">&quot;L(%)&quot;</span>, <span class="st">&quot;U(%)&quot;</span>)</a>
<a class="sourceLine" id="cb6-11" title="11"><span class="kw">print</span>(df, <span class="dt">row.names =</span> <span class="ot">FALSE</span>)</a>
<a class="sourceLine" id="cb6-12" title="12"><span class="co">#&gt;  CV(%)        L(%)         U(%)   cap</span></a>
<a class="sourceLine" id="cb6-13" title="13"><span class="co">#&gt;     29 80.00000000 125.00000000 lower</span></a>
<a class="sourceLine" id="cb6-14" title="14"><span class="co">#&gt;     30 80.00000000 125.00000000 lower</span></a>
<a class="sourceLine" id="cb6-15" title="15"><span class="co">#&gt;     35 77.23222179 129.47963646      </span></a>
<a class="sourceLine" id="cb6-16" title="16"><span class="co">#&gt;     40 74.61770240 134.01645559      </span></a>
<a class="sourceLine" id="cb6-17" title="17"><span class="co">#&gt;     45 72.15452039 138.59145547      </span></a>
<a class="sourceLine" id="cb6-18" title="18"><span class="co">#&gt;     50 69.83678198 143.19101936 upper</span></a>
<a class="sourceLine" id="cb6-19" title="19"><span class="co">#&gt;     51 69.83678198 143.19101936 upper</span></a></code></pre></div>
<p>In reference-scaling a so-called <em>mixed</em> (a.k.a. <em>aggregate</em>) criterion is applied. In order to pass BE,</p>
<ul>
<li>the 90% confidence interval has to lie entirely within the acceptance range <small><span class="math inline">\(\left[ {L,U} \right]\)</span></small> <em>and</em></li>
<li>the point estimate has to lie within 80.00 – 125.00%.</li>
</ul>
</div>
<div id="df_comp" class="section level4">
<h4>Degrees of freedom, comparison of methods</h4>
<p>The SAS code provided by the EMA in the Q&amp;A document does not specify how the degrees of freedom should be calculated in ‘Method B’. Hence, the default in <code>PROC MIXED</code>, namely <code>DDFM=CONTAIN</code> is applied, <em>i.e.</em>, <code>method.B(..., option = 2</code>). For incomplete data (missing periods) Satterthwaite’s approximation of the degrees of freedom, <em>i.e.</em>, <code>method.B(..., option = 1)</code> might be a better choice – if stated as such in the statistical analysis plan.</p>
<p>The EMA seemingly prefers ‘Method A’:</p>
<blockquote>
<p><em>A simple linear mixed model, which assumes identical within-subject variability (Method B), may be acceptable as long as results obtained with the two methods do not lead to different regu­la­tory decisions. However, in borderline cases […] additional analysis using Method A might be required.</em></p>
<p>— <a href="https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-positions-specific-questions-addressed-pharmacokinetics-working-party_en.pdf">Q&amp;A document</a> (January 2011 and later revisions)</p>
</blockquote>
<p>The half-width of the confidence interval in log-scale allows a comparison of methods (B <em>v.s.</em> A) where a higher value <em>might</em> point towards a more conservative decision.<a href="#fn11" class="footnote-ref" id="fnref11"><sup>11</sup></a> In the provided example data sets – with one exception – the con­clusion of BE (based on the mixed criterion) agrees between ‘Method A’ and ‘Method B’.<br />
However, for the highly incomplete data set 14 ‘Method B’ was <em>liberal</em> (passing by ANOVA but failing by the mixed effects model):</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1"><span class="co"># Compare Method B acc. to the GL with Method A for all reference data sets.</span></a>
<a class="sourceLine" id="cb7-2" title="2">ds &lt;-<span class="st"> </span><span class="kw">substr</span>(<span class="kw">grep</span>(<span class="st">&quot;rds&quot;</span>, <span class="kw">unname</span>(<span class="kw">unlist</span>(<span class="kw">data</span>(<span class="dt">package =</span> <span class="st">&quot;replicateBE&quot;</span>))),</a>
<a class="sourceLine" id="cb7-3" title="3">                  <span class="dt">value =</span> <span class="ot">TRUE</span>), <span class="dt">start =</span> <span class="dv">1</span>, <span class="dt">stop =</span> <span class="dv">5</span>)</a>
<a class="sourceLine" id="cb7-4" title="4"><span class="cf">for</span> (i <span class="cf">in</span> <span class="kw">seq_along</span>(ds)) {</a>
<a class="sourceLine" id="cb7-5" title="5">  A &lt;-<span class="st"> </span><span class="kw">method.A</span>(<span class="dt">print=</span><span class="ot">FALSE</span>, <span class="dt">details =</span> <span class="ot">TRUE</span>, <span class="dt">data =</span> <span class="kw">eval</span>(<span class="kw">parse</span>(<span class="dt">text =</span> ds[i])))<span class="op">$</span>BE</a>
<a class="sourceLine" id="cb7-6" title="6">  B &lt;-<span class="st"> </span><span class="kw">method.B</span>(<span class="dt">print=</span><span class="ot">FALSE</span>, <span class="dt">details =</span> <span class="ot">TRUE</span>, <span class="dt">data =</span> <span class="kw">eval</span>(<span class="kw">parse</span>(<span class="dt">text =</span> ds[i])))<span class="op">$</span>BE</a>
<a class="sourceLine" id="cb7-7" title="7">  r &lt;-<span class="st"> </span><span class="kw">paste0</span>(<span class="st">&quot;A &quot;</span>, A, <span class="st">&quot;, B &quot;</span>, B, <span class="st">&quot; \u2013 &quot;</span>)</a>
<a class="sourceLine" id="cb7-8" title="8">  <span class="kw">cat</span>(<span class="kw">paste0</span>(ds[i], <span class="st">&quot;:&quot;</span>), r)</a>
<a class="sourceLine" id="cb7-9" title="9">  <span class="cf">if</span> (A <span class="op">==</span><span class="st"> </span>B) {</a>
<a class="sourceLine" id="cb7-10" title="10">    <span class="kw">cat</span>(<span class="st">&quot;Methods agree.</span><span class="ch">\n</span><span class="st">&quot;</span>)</a>
<a class="sourceLine" id="cb7-11" title="11">  } <span class="cf">else</span> {</a>
<a class="sourceLine" id="cb7-12" title="12">    <span class="cf">if</span> (A <span class="op">==</span><span class="st"> &quot;fail&quot;</span> <span class="op">&amp;</span><span class="st"> </span>B <span class="op">==</span><span class="st"> &quot;pass&quot;</span>) {</a>
<a class="sourceLine" id="cb7-13" title="13">      <span class="kw">cat</span>(<span class="st">&quot;Method A is conservative.</span><span class="ch">\n</span><span class="st">&quot;</span>)</a>
<a class="sourceLine" id="cb7-14" title="14">    } <span class="cf">else</span> {</a>
<a class="sourceLine" id="cb7-15" title="15">      <span class="kw">cat</span>(<span class="st">&quot;Method B is conservative.</span><span class="ch">\n</span><span class="st">&quot;</span>)</a>
<a class="sourceLine" id="cb7-16" title="16">    }</a>
<a class="sourceLine" id="cb7-17" title="17">  }</a>
<a class="sourceLine" id="cb7-18" title="18">}</a>
<a class="sourceLine" id="cb7-19" title="19"><span class="co">#&gt; rds01: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-20" title="20"><span class="co">#&gt; rds02: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-21" title="21"><span class="co">#&gt; rds03: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-22" title="22"><span class="co">#&gt; rds04: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-23" title="23"><span class="co">#&gt; rds05: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-24" title="24"><span class="co">#&gt; rds06: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-25" title="25"><span class="co">#&gt; rds07: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-26" title="26"><span class="co">#&gt; rds08: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-27" title="27"><span class="co">#&gt; rds09: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-28" title="28"><span class="co">#&gt; rds10: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-29" title="29"><span class="co">#&gt; rds11: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-30" title="30"><span class="co">#&gt; rds12: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-31" title="31"><span class="co">#&gt; rds13: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-32" title="32"><span class="co">#&gt; rds14: A pass, B fail – Method B is conservative.</span></a>
<a class="sourceLine" id="cb7-33" title="33"><span class="co">#&gt; rds15: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-34" title="34"><span class="co">#&gt; rds16: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-35" title="35"><span class="co">#&gt; rds17: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-36" title="36"><span class="co">#&gt; rds18: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-37" title="37"><span class="co">#&gt; rds19: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-38" title="38"><span class="co">#&gt; rds20: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-39" title="39"><span class="co">#&gt; rds21: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-40" title="40"><span class="co">#&gt; rds22: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-41" title="41"><span class="co">#&gt; rds23: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-42" title="42"><span class="co">#&gt; rds24: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-43" title="43"><span class="co">#&gt; rds25: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-44" title="44"><span class="co">#&gt; rds26: A fail, B fail – Methods agree.</span></a>
<a class="sourceLine" id="cb7-45" title="45"><span class="co">#&gt; rds27: A pass, B pass – Methods agree.</span></a>
<a class="sourceLine" id="cb7-46" title="46"><span class="co">#&gt; rds28: A pass, B pass – Methods agree.</span></a></code></pre></div>
<p>Exploring data set 14:</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">A  &lt;-<span class="st"> </span><span class="kw">method.A</span>(<span class="dt">print =</span> <span class="ot">FALSE</span>, <span class="dt">details =</span> <span class="ot">TRUE</span>, <span class="dt">data =</span> rds14)</a>
<a class="sourceLine" id="cb8-2" title="2">B2 &lt;-<span class="st"> </span><span class="kw">method.B</span>(<span class="dt">print =</span> <span class="ot">FALSE</span>, <span class="dt">details =</span> <span class="ot">TRUE</span>, <span class="dt">data =</span> rds14, <span class="dt">option =</span> <span class="dv">2</span>)</a>
<a class="sourceLine" id="cb8-3" title="3">B1 &lt;-<span class="st"> </span><span class="kw">method.B</span>(<span class="dt">print =</span> <span class="ot">FALSE</span>, <span class="dt">details =</span> <span class="ot">TRUE</span>, <span class="dt">data =</span> rds14, <span class="dt">option =</span> <span class="dv">1</span>)</a>
<a class="sourceLine" id="cb8-4" title="4"><span class="co"># Rounding of CI according to the GL</span></a>
<a class="sourceLine" id="cb8-5" title="5">A[<span class="dv">15</span><span class="op">:</span><span class="dv">19</span>]  &lt;-<span class="st"> </span><span class="kw">round</span>(A[<span class="dv">15</span><span class="op">:</span><span class="dv">19</span>],  <span class="dv">2</span>) <span class="co"># all effects fixed</span></a>
<a class="sourceLine" id="cb8-6" title="6">B1[<span class="dv">15</span><span class="op">:</span><span class="dv">19</span>] &lt;-<span class="st"> </span><span class="kw">round</span>(B1[<span class="dv">15</span><span class="op">:</span><span class="dv">19</span>], <span class="dv">2</span>) <span class="co"># Satterthwaite&#39;s df</span></a>
<a class="sourceLine" id="cb8-7" title="7">B2[<span class="dv">15</span><span class="op">:</span><span class="dv">19</span>] &lt;-<span class="st"> </span><span class="kw">round</span>(B2[<span class="dv">15</span><span class="op">:</span><span class="dv">19</span>], <span class="dv">2</span>) <span class="co"># df acc. to Q&amp;A</span></a>
<a class="sourceLine" id="cb8-8" title="8">df &lt;-<span class="st"> </span><span class="kw">rbind</span>(A[<span class="kw">c</span>(<span class="dv">2</span>, <span class="dv">15</span><span class="op">:</span><span class="dv">23</span>)], B1[<span class="kw">c</span>(<span class="dv">2</span>, <span class="dv">15</span><span class="op">:</span><span class="dv">23</span>)], B2[<span class="kw">c</span>(<span class="dv">2</span>, <span class="dv">15</span><span class="op">:</span><span class="dv">23</span>)])</a>
<a class="sourceLine" id="cb8-9" title="9"><span class="kw">names</span>(df)[<span class="kw">c</span>(<span class="dv">1</span>, <span class="dv">10</span>)] &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="st">&quot;Meth.&quot;</span>, <span class="st">&quot;hw&quot;</span>)</a>
<a class="sourceLine" id="cb8-10" title="10">df<span class="op">$</span>hw &lt;-<span class="st"> </span><span class="kw">signif</span>(df<span class="op">$</span>hw, <span class="dv">5</span>)</a>
<a class="sourceLine" id="cb8-11" title="11"><span class="kw">print</span>(df[<span class="kw">order</span>(df<span class="op">$</span>BE, df<span class="op">$</span>hw, <span class="dt">decreasing =</span> <span class="kw">c</span>(<span class="ot">FALSE</span>, <span class="ot">TRUE</span>)), ],</a>
<a class="sourceLine" id="cb8-12" title="12">      <span class="dt">row.names =</span> <span class="ot">FALSE</span>)</a>
<a class="sourceLine" id="cb8-13" title="13"><span class="co">#&gt;  Meth. EL.lo(%) EL.hi(%) CI.lo(%) CI.hi(%) PE(%)   CI  GMR   BE      hw</span></a>
<a class="sourceLine" id="cb8-14" title="14"><span class="co">#&gt;    B-1    69.84   143.19    69.21   121.27 91.62 fail pass fail 0.28043</span></a>
<a class="sourceLine" id="cb8-15" title="15"><span class="co">#&gt;    B-2    69.84   143.19    69.21   121.28 91.62 fail pass fail 0.28046</span></a>
<a class="sourceLine" id="cb8-16" title="16"><span class="co">#&gt;      A    69.84   143.19    69.99   123.17 92.85 pass pass pass 0.28261</span></a></code></pre></div>
<p>Both variants of ‘Method B’ are more conservative than ‘Method A’. Before rounding the confidence interval, <code>option = 2</code> with 192 degrees of freedom would be more conservative (lower CL 69.21029) than <code>option = 1</code> with 197.44 degrees of freedom (lower CL 69.21286). However, given the incompleteness of this data set (four missings in period 2, twelve in period 3, and 19 in period 4), Satterthwaite’s degrees of freedom probably are the better choice.</p>
</div>
<div id="ola" class="section level4">
<h4>Outlier analysis</h4>
<p>It is an open issue how outliers should be handled.</p>
<blockquote>
<p><em>The applicant should justify that the calculated intra-subject variability is a reliable estimate and that it is not the result of outliers.</em></p>
<p>— <a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf#page=17" title="EMA, January 2010">BE Guideline</a></p>
</blockquote>
<p>Box plots were ‘suggested’ by the author as a joke [<em>sic</em>] at the EGA/EMA workshop, being aware of their non­para­metric nature and the EMA’s reluctance towards robust methods. Unfortunately, this <em>joke</em> was included in the Q&amp;A document.</p>
<blockquote>
<p><em>[…] a study could be acceptable if the bioequivalence requirements are met both including the outlier subject (using the scaled average bioequivalence approach and the within-subject CV with this sub­ject) and after exclusion of the outlier (using the within-subject CV without this subject).</em></p>
<p><em>An outlier test is not an expectation of the medicines agencies but outliers could be shown by a box plot. This would allow the medicines agencies to compare the data between them.</em></p>
<p>— <a href="https://www.medicinesforeurope.com/wp-content/uploads/2016/03/EGA_BEQ_QA_WEB_QA_1_32.pdf" title="EGA/EMA workshop, June 2010">Q&amp;A</a></p>
</blockquote>
<p>With the additional argument <code>ola = TRUE</code> in <code>method.A()</code> and <code>method.B()</code> an outlier analysis is performed, where the default <code>fence = 2</code><a href="#fn12" class="footnote-ref" id="fnref12"><sup>12</sup></a> is used.</p>
<p>Note that results might slightly differ depending on software’s algorithms. Example with methods implemented in R:</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="co">### Compare different types with some random data</span></a>
<a class="sourceLine" id="cb9-2" title="2">x &lt;-<span class="st"> </span><span class="kw">rnorm</span>(<span class="dv">48</span>)</a>
<a class="sourceLine" id="cb9-3" title="3">p &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">25</span>, <span class="dv">50</span>, <span class="dv">75</span>)<span class="op">/</span><span class="dv">100</span></a>
<a class="sourceLine" id="cb9-4" title="4">q &lt;-<span class="st"> </span><span class="kw">matrix</span>(<span class="dt">data =</span> <span class="st">&quot;&quot;</span>, <span class="dt">nrow =</span> <span class="dv">9</span>, <span class="dt">ncol =</span> <span class="dv">4</span>,</a>
<a class="sourceLine" id="cb9-5" title="5">            <span class="dt">dimnames=</span><span class="kw">list</span>(<span class="kw">paste</span>(<span class="st">&quot;type&quot;</span>, <span class="dv">1</span><span class="op">:</span><span class="dv">9</span>),</a>
<a class="sourceLine" id="cb9-6" title="6">                          <span class="kw">c</span>(<span class="st">&quot;1st quart.&quot;</span>, <span class="st">&quot;median&quot;</span>, <span class="st">&quot;3rd quart.&quot;</span>,</a>
<a class="sourceLine" id="cb9-7" title="7">                            <span class="st">&quot;software / default&quot;</span>)))</a>
<a class="sourceLine" id="cb9-8" title="8"><span class="cf">for</span> (i <span class="cf">in</span> <span class="dv">1</span><span class="op">:</span><span class="dv">9</span>) {</a>
<a class="sourceLine" id="cb9-9" title="9">  q[i, <span class="dv">1</span><span class="op">:</span><span class="dv">3</span>] &lt;-<span class="st"> </span><span class="kw">sprintf</span>(<span class="st">&quot;%.5f&quot;</span>, <span class="kw">quantile</span>(x, <span class="dt">prob =</span> p, <span class="dt">type =</span> i))</a>
<a class="sourceLine" id="cb9-10" title="10">}</a>
<a class="sourceLine" id="cb9-11" title="11">q[<span class="kw">c</span>(<span class="dv">2</span>, <span class="dv">4</span><span class="op">:</span><span class="dv">8</span>), <span class="dv">4</span>] &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="st">&quot;SAS, Stata&quot;</span>, <span class="st">&quot;SciPy&quot;</span>, <span class="st">&quot;&quot;</span>,</a>
<a class="sourceLine" id="cb9-12" title="12">                     <span class="st">&quot;Phoenix, Minitab, SPSS&quot;</span>,</a>
<a class="sourceLine" id="cb9-13" title="13">                     <span class="st">&quot;R, S, MATLAB, Excel&quot;</span>,</a>
<a class="sourceLine" id="cb9-14" title="14">                     <span class="st">&quot;Maple&quot;</span>)</a>
<a class="sourceLine" id="cb9-15" title="15"><span class="kw">print</span>(<span class="kw">as.data.frame</span>(q))</a>
<a class="sourceLine" id="cb9-16" title="16"><span class="co">#&gt;        1st quart.  median 3rd quart.     software / default</span></a>
<a class="sourceLine" id="cb9-17" title="17"><span class="co">#&gt; type 1   -0.64372 0.11516    0.69060                       </span></a>
<a class="sourceLine" id="cb9-18" title="18"><span class="co">#&gt; type 2   -0.59117 0.13205    0.72718             SAS, Stata</span></a>
<a class="sourceLine" id="cb9-19" title="19"><span class="co">#&gt; type 3   -0.64372 0.11516    0.69060                       </span></a>
<a class="sourceLine" id="cb9-20" title="20"><span class="co">#&gt; type 4   -0.64372 0.11516    0.69060                  SciPy</span></a>
<a class="sourceLine" id="cb9-21" title="21"><span class="co">#&gt; type 5   -0.59117 0.13205    0.72718                       </span></a>
<a class="sourceLine" id="cb9-22" title="22"><span class="co">#&gt; type 6   -0.61745 0.13205    0.74547 Phoenix, Minitab, SPSS</span></a>
<a class="sourceLine" id="cb9-23" title="23"><span class="co">#&gt; type 7   -0.56490 0.13205    0.70889    R, S, MATLAB, Excel</span></a>
<a class="sourceLine" id="cb9-24" title="24"><span class="co">#&gt; type 8   -0.59993 0.13205    0.73328                  Maple</span></a>
<a class="sourceLine" id="cb9-25" title="25"><span class="co">#&gt; type 9   -0.59774 0.13205    0.73175</span></a></code></pre></div>
<ul>
<li>Box plots of studentized<a href="#fn13" class="footnote-ref" id="fnref13"><sup>13</sup></a> and standarized<a href="#fn14" class="footnote-ref" id="fnref14"><sup>14</sup></a> model residuals are constructed.<a href="#fn15" class="footnote-ref" id="fnref15"><sup>15</sup></a></li>
<li>Potential outliers are flagged based on the argument <code>fence</code> provided by the user.</li>
<li>With the additional argument <code>verbose = TRUE</code> detailed information is shown in the console.</li>
</ul>
<p>Example for the reference data set 01:</p>
<pre><code>Outlier analysis
 (externally) studentized residuals
 Limits (2×IQR whiskers): -1.717435, 1.877877
 Outliers:
 subject sequence  stud.res
      45     RTRT -6.656940
      52     RTRT  3.453122

 standarized (internally studentized) residuals
 Limits (2×IQR whiskers): -1.69433, 1.845333
 Outliers:
 subject sequence stand.res
      45     RTRT -5.246293
      52     RTRT  3.214663</code></pre>
<p>If based on studentized residuals outliers are detected, additionally to the scaled limits based on the complete reference data, tighter limits are calculated based on <em>CV<sub>wR</sub></em> after exclusion of outliers and BE assessed with the new limits. Standardized residuals are shown for informational purposes only and are not used for exclusion of outliers.</p>
<p>Output for the reference data set 01 (re-ordered for clarity):</p>
<pre><code>CVwR               :  46.96% (reference-scaling applicable)
swR                :   0.44645
Expanded limits    :  71.23% ... 140.40% [100exp(±0.760·swR)]
Assessment based on original CVwR 46.96%
────────────────────────────────────────
Confidence interval: 107.11% ... 124.89%  pass
Point estimate     : 115.66%              pass
Mixed (CI &amp; PE)    :                      pass
 ╟────────┼─────────────────────┼───────■────────◊─────────■───────────────╢

Outlier fence      :  2×IQR of studentized residuals.
Recalculation due to presence of 2 outliers (subj. 45|52)
─────────────────────────────────────────────────────────
CVwR (outl. excl.) :  32.16% (reference-scaling applicable)
swR (recalculated) :   0.31374
Expanded limits    :  78.79% ... 126.93% [100exp(±0.760·swR)]
Assessment based on recalculated CVwR 32.16%
────────────────────────────────────────────
Confidence interval: pass
Point estimate     : pass
Mixed (CI &amp; PE)    : pass
         ╟┼─────────────────────┼───────■────────◊─────────■─╢</code></pre>
<p>Note that the PE and its CI are not affected since the entire data are used and therefore, these values not reported in the second analysis (only the conclusion of the assessement).<br />
The line plot is given for informational puposes (its resolution is only ~0.5%). The filled squares <code> ■ </code> are the lower and upper 90% confidence limits, the rhombus <code> ◊ </code> the point estimate, the vertical lines <code> │ </code> at 100% and the PE restriction (80.00 – 125.00%), and the double vertical lines <code> ║ </code> the expanded limits. The PE and CI take pre­se­dence over other symbols. In this case the upper limit of the PE restriction is not visible.<br />
Since both analyses arrive at the same conclusion, the study should be acceptable according to the Q&amp;A document.</p>
</div>
</div>
<div id="app_out" class="section level3">
<h3>Applicability, outlook</h3>
<p>The EMA’s approach of reference-scaling for highly variable drugs / drug products is currently recommended in other jurisdictions as well (<em>e.g.</em>, the WHO; ASEAN States, Australia, Brazil, Egypt, the Russian Federation, the Eurasian Economic Union, the East African Community, New Zealand).</p>
<p>The WHO opened a <a href="https://extranet.who.int/prequal/sites/default/files/documents/AUC_criteria_June2017.pdf" title="Guidance Document 09 June 2017">pilot phase</a> exploring reference-scaling for AUC (four period full replicate studies are mandatory in order to assess the variability associated with each product). It is not evident how this assessment should be done. In Population Bioequivalence (PBE) and Individual Bioequivalence (IBE) the <em>s<sub>wT</sub></em>/<em>s<sub>wR</sub></em> ratio was assessed and similar variability was concluded for a ratio within 0.667 – 1.500. However, the power of comparing variabilities in a study designed to demonstrate ABE is low. This was the main reason why PBE and IBE were not implemented in regulatory practice. An alternative approach is given in the FDA’s <a href="https://www.accessdata.fda.gov/drugsatfda_docs/psg/Warfarin_Sodium_tab_09218_RC12-12.pdf" title="Draft recommended Dec 2012">guidance on warfarin</a>. Variabilities are considered comparable if the upper confidence limit of <em>σ<sub>wT</sub></em>/<em>σ<sub>wR</sub></em> is ≤2.5.</p>
</div>
<div id="cross" class="section level3">
<h3>Cross-validation</h3>
<p>Results of reference data sets agree with ones obtained in SAS (9.3, 9.4) and Phoenix/WinNonlin (6.4 – 8.1).</p>
</div>
<div id="contr" class="section level3">
<h3>Contributors</h3>
<ul>
<li>Helmut Schütz (Author)</li>
<li>Michael Tomashevskiy (Contributor)</li>
<li>Detlew Labes (Contributor)</li>
</ul>
</div>
<div id="session" class="section level3">
<h3>Session Information</h3>
<p>Inspect this information for reproducibility. Of particular importance are the versions of R and the packages used to create this workflow. It is considered good practice to record this information with every analysis.</p>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">options</span>(<span class="dt">width =</span> <span class="dv">80</span>)</a>
<a class="sourceLine" id="cb12-2" title="2">devtools<span class="op">::</span><span class="kw">session_info</span>()</a>
<a class="sourceLine" id="cb12-3" title="3"><span class="co">#&gt; - Session info ---------------------------------------------------------------</span></a>
<a class="sourceLine" id="cb12-4" title="4"><span class="co">#&gt;  setting  value                       </span></a>
<a class="sourceLine" id="cb12-5" title="5"><span class="co">#&gt;  version  R version 3.6.0 (2019-04-26)</span></a>
<a class="sourceLine" id="cb12-6" title="6"><span class="co">#&gt;  os       Windows 7 x64 SP 1          </span></a>
<a class="sourceLine" id="cb12-7" title="7"><span class="co">#&gt;  system   x86_64, mingw32             </span></a>
<a class="sourceLine" id="cb12-8" title="8"><span class="co">#&gt;  ui       RTerm                       </span></a>
<a class="sourceLine" id="cb12-9" title="9"><span class="co">#&gt;  language EN                          </span></a>
<a class="sourceLine" id="cb12-10" title="10"><span class="co">#&gt;  collate  C                           </span></a>
<a class="sourceLine" id="cb12-11" title="11"><span class="co">#&gt;  ctype    German_Germany.1252         </span></a>
<a class="sourceLine" id="cb12-12" title="12"><span class="co">#&gt;  tz       Europe/Vienna               </span></a>
<a class="sourceLine" id="cb12-13" title="13"><span class="co">#&gt;  date     2019-06-07                  </span></a>
<a class="sourceLine" id="cb12-14" title="14"><span class="co">#&gt; </span></a>
<a class="sourceLine" id="cb12-15" title="15"><span class="co">#&gt; - Packages -------------------------------------------------------------------</span></a>
<a class="sourceLine" id="cb12-16" title="16"><span class="co">#&gt;  package       * version    date       lib source        </span></a>
<a class="sourceLine" id="cb12-17" title="17"><span class="co">#&gt;  assertthat      0.2.1      2019-03-21 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-18" title="18"><span class="co">#&gt;  backports       1.1.4      2019-04-10 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-19" title="19"><span class="co">#&gt;  boot            1.3-22     2019-04-02 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-20" title="20"><span class="co">#&gt;  callr           3.2.0      2019-03-15 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-21" title="21"><span class="co">#&gt;  cellranger      1.1.0      2016-07-27 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-22" title="22"><span class="co">#&gt;  cli             1.1.0      2019-03-19 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-23" title="23"><span class="co">#&gt;  colorspace      1.4-1      2019-03-18 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-24" title="24"><span class="co">#&gt;  crayon          1.3.4      2017-09-16 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-25" title="25"><span class="co">#&gt;  cubature        2.0.3      2018-12-18 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-26" title="26"><span class="co">#&gt;  desc            1.2.0      2018-05-01 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-27" title="27"><span class="co">#&gt;  devtools        2.0.2      2019-04-08 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-28" title="28"><span class="co">#&gt;  digest          0.6.19     2019-05-20 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-29" title="29"><span class="co">#&gt;  dplyr           0.8.1      2019-05-14 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-30" title="30"><span class="co">#&gt;  evaluate        0.14       2019-05-28 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-31" title="31"><span class="co">#&gt;  fs              1.3.1      2019-05-06 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-32" title="32"><span class="co">#&gt;  ggplot2         3.1.1      2019-04-07 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-33" title="33"><span class="co">#&gt;  glue            1.3.1      2019-03-12 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-34" title="34"><span class="co">#&gt;  gtable          0.3.0      2019-03-25 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-35" title="35"><span class="co">#&gt;  htmltools       0.3.6      2017-04-28 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-36" title="36"><span class="co">#&gt;  knitr           1.23       2019-05-18 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-37" title="37"><span class="co">#&gt;  lattice         0.20-38    2018-11-04 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-38" title="38"><span class="co">#&gt;  lazyeval        0.2.2      2019-03-15 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-39" title="39"><span class="co">#&gt;  lme4            1.1-21     2019-03-05 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-40" title="40"><span class="co">#&gt;  lmerTest        3.1-0      2019-02-11 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-41" title="41"><span class="co">#&gt;  magrittr        1.5        2014-11-22 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-42" title="42"><span class="co">#&gt;  MASS            7.3-51.4   2019-03-31 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-43" title="43"><span class="co">#&gt;  Matrix          1.2-17     2019-03-22 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-44" title="44"><span class="co">#&gt;  memoise         1.1.0      2017-04-21 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-45" title="45"><span class="co">#&gt;  minqa           1.2.4      2014-10-09 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-46" title="46"><span class="co">#&gt;  munsell         0.5.0      2018-06-12 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-47" title="47"><span class="co">#&gt;  mvtnorm         1.0-10     2019-03-05 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-48" title="48"><span class="co">#&gt;  nlme            3.1-140    2019-05-12 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-49" title="49"><span class="co">#&gt;  nloptr          1.2.1      2018-10-03 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-50" title="50"><span class="co">#&gt;  numDeriv        2016.8-1   2016-08-27 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-51" title="51"><span class="co">#&gt;  pillar          1.4.1      2019-05-28 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-52" title="52"><span class="co">#&gt;  pkgbuild        1.0.3      2019-03-20 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-53" title="53"><span class="co">#&gt;  pkgconfig       2.0.2      2018-08-16 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-54" title="54"><span class="co">#&gt;  pkgload         1.0.2      2018-10-29 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-55" title="55"><span class="co">#&gt;  plyr            1.8.4      2016-06-08 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-56" title="56"><span class="co">#&gt;  PowerTOST       1.4.7.9000 2019-05-14 [2] local         </span></a>
<a class="sourceLine" id="cb12-57" title="57"><span class="co">#&gt;  prettyunits     1.0.2      2015-07-13 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-58" title="58"><span class="co">#&gt;  processx        3.3.1      2019-05-08 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-59" title="59"><span class="co">#&gt;  ps              1.3.0      2018-12-21 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-60" title="60"><span class="co">#&gt;  purrr           0.3.2      2019-03-15 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-61" title="61"><span class="co">#&gt;  R6              2.4.0      2019-02-14 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-62" title="62"><span class="co">#&gt;  Rcpp            1.0.1      2019-03-17 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-63" title="63"><span class="co">#&gt;  readxl          1.3.1      2019-03-13 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-64" title="64"><span class="co">#&gt;  remotes         2.0.4      2019-04-10 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-65" title="65"><span class="co">#&gt;  replicateBE   * 1.0.5.9003 2019-06-06 [1] local         </span></a>
<a class="sourceLine" id="cb12-66" title="66"><span class="co">#&gt;  rlang           0.3.4      2019-04-07 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-67" title="67"><span class="co">#&gt;  rmarkdown       1.13       2019-05-22 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-68" title="68"><span class="co">#&gt;  rprojroot       1.3-2      2018-01-03 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-69" title="69"><span class="co">#&gt;  scales          1.0.0      2018-08-09 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-70" title="70"><span class="co">#&gt;  sessioninfo     1.1.1      2018-11-05 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-71" title="71"><span class="co">#&gt;  stringi         1.4.3      2019-03-12 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-72" title="72"><span class="co">#&gt;  stringr         1.4.0      2019-02-10 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-73" title="73"><span class="co">#&gt;  TeachingDemos   2.10       2016-02-12 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-74" title="74"><span class="co">#&gt;  testthat        2.1.1      2019-04-23 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-75" title="75"><span class="co">#&gt;  tibble          2.1.2      2019-05-29 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-76" title="76"><span class="co">#&gt;  tidyselect      0.2.5      2018-10-11 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-77" title="77"><span class="co">#&gt;  usethis         1.5.0      2019-04-07 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-78" title="78"><span class="co">#&gt;  withr           2.1.2      2018-03-15 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-79" title="79"><span class="co">#&gt;  xfun            0.7        2019-05-14 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-80" title="80"><span class="co">#&gt;  yaml            2.2.0      2018-07-25 [2] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb12-81" title="81"><span class="co">#&gt; </span></a>
<a class="sourceLine" id="cb12-82" title="82"><span class="co">#&gt; [1] C:/Users/HS/AppData/Local/Temp/Rtmpi0zDXg/Rinst262c77c747ba</span></a>
<a class="sourceLine" id="cb12-83" title="83"><span class="co">#&gt; [2] D:/Program Files/R/R-3.6.0/library</span></a></code></pre></div>
</div>
<div class="footnotes">
<hr />
<ol>
<li id="fn1"><p>Schütz H, Tomashevskiy M, Labes D, Shitova A, González-de la Parra M, Fuglsang A. <em>Reference Data­sets for Studies in a Replicate Design intended for Average Bioequivalence with Expanding Limits.</em> Manu­script in pre­paration 2019.<a href="#fnref1" class="footnote-back">↩</a></p></li>
<li id="fn2"><p>Gulf Cooperation Council: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.<a href="#fnref2" class="footnote-back">↩</a></p></li>
<li id="fn3"><p>Confounded effects (design <em>not recommended</em>).<a href="#fnref3" class="footnote-back">↩</a></p></li>
<li id="fn4"><p>Confounded effects (design <em>not recommended</em>).<a href="#fnref4" class="footnote-back">↩</a></p></li>
<li id="fn5"><p>Balaam’s design (<em>not recommended</em> due to its poor power characteristics).<a href="#fnref5" class="footnote-back">↩</a></p></li>
<li id="fn6"><p>Extra-reference design; biased in the presence of period effects (design <em>not recommended</em>).<a href="#fnref6" class="footnote-back">↩</a></p></li>
<li id="fn7"><p>Napierian logarithm (base <em>e</em>). The decadic logarithm (base 10) is not supported).<a href="#fnref7" class="footnote-back">↩</a></p></li>
<li id="fn8"><p>Contradics the law of simplicity. Such a nesting is superfluous since in BE trials subjects are uniquely coded. If, say, subject <code>1</code> is allocated to sequence <code>TRTR</code> there is not yet ‘another’ subject <code>1</code> allocated to sequence <code>RTRT</code>. This explains the many lines in SAS <code>PROC GML</code> given with <code>.</code> and in Phoenix/WinNonlin as <code>not estimable</code>.<a href="#fnref8" class="footnote-back">↩</a></p></li>
<li id="fn9"><p><a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf#page=17" title="EMA, 20 January 2010">Guideline on the Investigation of Bioequivalence</a><a href="#fnref9" class="footnote-back">↩</a></p></li>
<li id="fn10"><p><a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmacokinetic-clinical-evaluation-modified-release-dosage-forms_en.pdf#page=27" title="EMA, 20 November 2014">Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms</a><a href="#fnref10" class="footnote-back">↩</a></p></li>
<li id="fn11"><p>Of course, only if the point estimates are identical.<a href="#fnref11" class="footnote-back">↩</a></p></li>
<li id="fn12"><p>The fences are the lowest data value still within <em>m</em>×IQR of the lower quartile, and the highest value still within <em>m</em>×IQR of the upper quartile, where IQR is the interquartile range (difference between the 3<sup>rd</sup> and 1<sup>st</sup> quartiles). Data outside fences are considered outliers. Decreasing the multiplier <em>m</em> to <em>e.g.</em>, 1.5 might result in many outliers whereas increasing the multiplier in only a few.<br />
Note that different methods exist to calculate quartiles (nine are available in R, where the default is <code>type = 7</code>). R’s default is used by S, MATLAB, and Excel. Phoenix/WinNonlin, Minitab, and SPSS use <code>type = 6</code>, ScyPy uses <code>type = 4</code>, whereas the default in SAS and Stata is <code>type = 2</code> (though others are available as well).<a href="#fnref12" class="footnote-back">↩</a></p></li>
<li id="fn13"><p><em>Externally</em> studentized: <span class="math inline">\(\widehat{\sigma}_{(i)}^2={1 \over n-m-1}\sum_{\begin{smallmatrix}j = 1\\j \ne i\end{smallmatrix}}^n \widehat{\varepsilon\,}_j^{\,2}\)</span><a href="#fnref13" class="footnote-back">↩</a></p></li>
<li id="fn14"><p><em>Internally</em> studentized: <span class="math inline">\(\widehat{\sigma}^2={1 \over n-m}\sum_{j=1}^n \widehat{\varepsilon\,}_j^{\,2}\)</span><a href="#fnref14" class="footnote-back">↩</a></p></li>
<li id="fn15"><p>Both are available in SAS and R, whereas only the latter in <em>e.g.</em>, Phoenix/WinNonlin. In general the former are slightly more restrictive. Which one will be used has to be stated in the SAP.<a href="#fnref15" class="footnote-back">↩</a></p></li>
</ol>
</div>



<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
